Cargando…
Strategies to improve lung absorption of intratracheally administered compounds in Drug Discovery
Autores principales: | Calama, Elena, Vives, Montserrat, Ramis, Isabel, Espinosa, Sonia, Pérez, Juan, Huerta, Josep Maria, De Alba, Jorge, Eichhorn, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3750912/ http://dx.doi.org/10.1186/1476-9255-10-S1-P35 |
Ejemplares similares
-
Effect of the circadian cycle in Late Asthmatic Response (LAR). Comparison between two allergic asthma models in rats and mice
por: Otal, Raquel, et al.
Publicado: (2013) -
Poly I:C causes exacerbation in a murine allergic inflammation model driven by house dust mite in Freund's complete adjuvant
por: De Alba, Jorge, et al.
Publicado: (2013) -
Safety and efficacy of intratracheal DNase with physiotherapy in severe status asthmaticus
por: Nyman, A, et al.
Publicado: (2011) -
THE ABSORPTION OF ADRENALIN AFTER INTRATRACHEAL INJECTION
por: Auer, J., et al.
Publicado: (1916) -
The kinetics of IL-17 production in the lungs and plasma of mice after intratracheal infection with Klebsiella pneumoniae
por: Marchesi, Vanja Vasiljev, et al.
Publicado: (2007)